tiprankstipranks
Trending News
More News >
Soleno Therapeutics Inc (SLNO)
NASDAQ:SLNO
US Market

Soleno Therapeutics (SLNO) Income Statement

Compare
929 Followers

Soleno Therapeutics Income Statement

Last quarter (Q4 2025), Soleno Therapeutics's total revenue was $91.73M, an increase of Infinity% from the same quarter last year. In Q4, Soleno Therapeutics's net income was $43.36M. See Soleno Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Mar 22
Total Revenue
$ 190.41M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 187.71M$ 0.00$ -1.96M$ 0.00$ 0.00
Operating Expenses
$ 172.75M$ 187.67M$ 41.38M$ 24.40M$ 31.53M
Depreciation and Amortization
$ 2.02M$ 1.99M$ 1.96M$ 1.96M$ 1.96M
EBITDA
$ 28.38M$ -173.63M$ -37.03M$ -22.10M$ -30.30M
Operating Income
$ 14.95M$ -187.67M$ -41.38M$ -24.40M$ -31.53M
Other Income/Expenses
$ 5.94M$ 11.82M$ 2.40M$ 330.00K$ 618.00K
Pretax Income
$ 20.89M$ -175.85M$ -38.99M$ -24.07M$ -30.91M
Net Income
$ 20.89M$ -175.85M$ -38.99M$ -24.07M$ -30.91M
Per Share Metrics
Basic EPS
$ 0.41$ -4.38$ -2.36$ -2.87$ -5.81
Diluted EPS
$ 0.39$ -4.38$ -2.36$ -2.87$ -5.81
Weighted Average Shares Outstanding
53.18M 40.18M 16.49M 8.40M 5.32M
Weighted Average Shares Outstanding (Diluted)
54.33M 40.18M 16.49M 8.40M 5.32M
Currency in USD

Soleno Therapeutics Earnings and Revenue History